Prime Medicine Inc
For the period ended Dec 31, 2023. Filed Mar 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 1, 2024
PRME$4.30-7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets F-
CONSOLIDATED BALANCE SHEETS
| December 31, | ||
|---|---|---|
| (in thousands, except share and per share amounts) | 2023 | 2022 |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $41,574 | $187,620 |
| Short-term investments | 74,639 | 98,467 |
| Short-term investment — related party | 5,452 | 7,834 |
| Prepaid expenses | 19,057 | 2,451 |
| Other current assets | 2,254 | 246 |
| Total current assets | 142,976 | 296,618 |
| Property and equipment, net | 22,659 | 19,009 |
| Operating lease right-of-use assets | 13,941 | 29,545 |
| Restricted cash | 13,496 | 13,496 |
| Other assets | 779 | 1,646 |
| Total assets | $193,851 | $360,314 |
| Liabilities and Stockholders’ Deficit | ||
| Current liabilities: | ||
| Accounts payable | $19,537 | $4,332 |
| Accrued expenses and other current liabilities (1) | 14,110 | 10,688 |
| Accrued settlement payment — related party | 13,500 | — |
| Operating lease liability | 9,276 | 11,694 |
| Total current liabilities | 56,423 | 26,714 |
| Operating lease liability, net of current | 4,357 | 17,051 |
| Non current deferred tax liability | — | 279 |
| Total liabilities | 60,780 | 44,044 |
| Commitments and contingencies (Note 12) | ||
| Stockholders’ equity | ||
| Common stock, par value of $0.00001 per share; 775,000,000 shares authorized; 97,377,121 and 97,209,213 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 2 | 2 |
| Additional paid-in capital | 624,414 | 609,849 |
| Accumulated other comprehensive loss | (15) | (384) |
| Accumulated deficit | (491,330) | (293,197) |
| Total stockholders’ equity | 133,071 | 316,270 |
| Total liabilities and stockholders’ equity | $193,851 | $360,314 |
(1)Includes related party amount of $0.3 million as of December 31, 2022.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.